Globus Medical Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskele...
Latest News
6 hours ago · seekingalpha.com
Globus Medical: The Shrinking Robot Line Hides A Growing AnnuityGlobus Medical is leveraging flexible leasing models to expand its installed base, prioritizing recurring high-margin implant sales over upfront capital revenue. GMED's post-NuVasive integration is driving structurally higher margins, with adjusted EBITDA margins rising to 35.4% and free cash flow nearly doubling year-over-year. Despite a segment revenue decline, ExcelsiusGPS placements grew 25%, supporting a transition to a more recurring, cash-generative business model.
6 hours ago · zacks.com
GMED vs. AXGN: Which Stock Should Value Investors Buy Now?Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and AxoGen (AXGN). But which of these two companies is the best option for those looking for undervalued stocks?
8 hours ago · zacks.com
Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a BetThe consensus price target hints at a 30.5% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
8 hours ago · zacks.com
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
4 days ago · zacks.com
2 Healthcare Technology Stocks for a Digital Health BoomGMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.
17 days ago · zacks.com
GMED or AXGN: Which Is the Better Value Stock Right Now?Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or AxoGen (AXGN). But which of these two stocks offers value investors a better bang for their buck right now?
19 days ago · globenewswire.com
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41st Annual North American Spine Society (NASS) Meeting in San Antonio, Texas, from October 14-17.
21 days ago · globenewswire.com
Globus Medical Schedules Third Quarter Earnings Release and Conference CallAUDUBON, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Thursday, November 5, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
26 days ago · zacks.com
Reasons to Add Globus Medical Stock to Your Portfolio NowGMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a debt-free balance sheet support its appeal.
28 days ago · zacks.com
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher ScientificGlobus Medical, Intuitive Surgical and Thermo Fisher Scientific have been highlighted in this Industry Outlook article.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove GMED